Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
暂无分享,去创建一个
[1] B. Spencer‐Dene,et al. FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. , 2011, Cancer research.
[2] N. Saini,et al. Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases , 2010, Molecular Cancer.
[3] M. Ittmann,et al. The function of microRNAs, small but potent molecules, in human prostate cancer , 2010, Prostate Cancer and Prostatic Diseases.
[4] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[5] S. Safe,et al. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. , 2010, Endocrinology.
[6] S. Pfeffer,et al. Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. , 2010, RNA.
[7] S. Shenouda,et al. MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.
[8] B. Spencer‐Dene,et al. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours , 2009, Endocrine-related cancer.
[9] V. Scaria,et al. Upregulation of miR-23a∼27a∼24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells , 2009, PloS one.
[10] Min Liu,et al. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. , 2009, Cancer letters.
[11] Elodie Portales-Casamar,et al. Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. , 2009, Blood.
[12] Jinjun Li,et al. Upregulation of miR‐23a∼27a∼24 decreases transforming growth factor‐beta‐induced tumor‐suppressive activities in human hepatocellular carcinoma cells , 2008, International journal of cancer.
[13] George A. Calin,et al. Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer , 2008, The Prostate.
[14] C. Tepper,et al. microRNAs and prostate cancer , 2008, Journal of cellular and molecular medicine.
[15] Jae Hoon Kim,et al. MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.
[16] D. Tindall,et al. FOXOs, cancer and regulation of apoptosis , 2008, Oncogene.
[17] C. Creighton,et al. Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.
[18] T. Golub,et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia , 2007, Proceedings of the National Academy of Sciences.
[19] Stephen Safe,et al. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. , 2007, Cancer research.
[20] Anton J. Enright,et al. Genomic analysis of human microRNA transcripts , 2007, Proceedings of the National Academy of Sciences.
[21] T. Tammela,et al. MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.
[22] R. Scott,et al. The 3′ untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation , 2007, Breast Cancer Research and Treatment.
[23] D. Dart,et al. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity , 2007, Oncogene.
[24] Yonghong Xiao,et al. FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.
[25] P. Rennie,et al. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. , 2006, Cancer research.
[26] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[27] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[28] L. Murphy,et al. The Prohibitins: emerging roles in diverse functions , 2006, Journal of cellular and molecular medicine.
[29] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[30] Minchen Chien,et al. Prognostic Values of microRNAs in Colorectal Cancer , 2006, Biomarker insights.
[31] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] Volker Brinkmann,et al. Prohibitin is required for Ras-induced Raf–MEK–ERK activation and epithelial cell migration , 2005, Nature Cell Biology.
[33] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[34] S. Balk,et al. The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists* , 2005, Journal of Biological Chemistry.
[35] B. Cullen,et al. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha , 2005, The EMBO journal.
[36] Sanghyuk Lee,et al. MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.
[37] E. Lam,et al. Androgens target prohibitin to regulate proliferation of prostate cancer cells , 2004, Oncogene.
[38] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Chellappan,et al. Prohibitin Induces the Transcriptional Activity of p53 and Is Exported from the Nucleus upon Apoptotic Signaling* , 2003, Journal of Biological Chemistry.
[40] J. C. Ghosh,et al. Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT* , 2003, The Journal of Biological Chemistry.
[41] J. Padmanabhan,et al. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression , 2002, Oncogene.
[42] J. Wong,et al. p300 Requires Its Histone Acetyltransferase Activity and SRC-1 Interaction Domain To Facilitate Thyroid Hormone Receptor Activation in Chromatin , 2000, Molecular and Cellular Biology.
[43] Helmut Klocker,et al. Rapid signalling by androgen receptor in prostate cancer cells , 1999, Oncogene.
[44] Walter Neupert,et al. Prohibitins Regulate Membrane Protein Degradation by the m-AAA Protease in Mitochondria , 1999, Molecular and Cellular Biology.
[45] C. Allis,et al. Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.
[46] D. J. Jamieson,et al. The prohibitin family of mitochondrial proteins regulate replicative lifespan , 1997, Current Biology.
[47] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.
[48] E. Jupe,et al. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[49] M. Reth,et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin‐related protein. , 1994, The EMBO journal.
[50] M. Skolnick,et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. , 1992, Cancer research.
[51] H. Okayama,et al. High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.
[52] F. Hamdy,et al. Platinum Priority – Collaborative Review – Prostate Cancer MicroRNA in Prostate , Bladder , and Kidney Cancer : A Systematic Review , 2011 .
[53] N. Kyprianou,et al. Prohibitin regulates TGF‐β induced apoptosis as a downstream effector of smad‐dependent and ‐independent signaling , 2010, The Prostate.
[54] É. Várallyay,et al. MicroRNA detection by northern blotting using locked nucleic acid probes , 2008, Nature Protocols.
[55] V. Kim,et al. In vitro and in vivo assays for the activity of Drosha complex. , 2007, Methods in enzymology.
[56] B. Cullen,et al. Sequence requirements for micro RNA processing and function in human cells. , 2003, RNA.
[57] T. Visakorpi,et al. Androgen receptor gene and hormonal therapy failure of prostate cancer. , 1998, The American journal of pathology.